Literature DB >> 8825782

Characterization of a post-translational modification of Campylobacter flagellin: identification of a sero-specific glycosyl moiety.

P Doig1, N Kinsella, P Guerry, T J Trust.   

Abstract

The flagellins of Campylobacter spp. differ antigenically. In variants of C. coli strain VC167, two antigenic flagellin types determined by sero-specific antibodies have been described (termed T1 and T2). Post-translational modification has been suggested to be responsible for T1 and T2 epitopes, and, using mild periodate treatment and biotin hydrazide labelling, flagellin from both VC167-T1 and T2 were shown to be glycosylated. Glycosylation was also shown to be present on other Campylobacter flagellins. The ability to label all Campylobacter flagellins examined with the lectin LFA demonstrated the presence of a terminal sialic acid moiety. Furthermore, mild periodate treatment of the flagellins of VC167 eliminated reactivity with T1 and T2 specific antibodies LAH1 and LAH2, respectively, and LFA could also compete with LAH1 and LAH2 antibodies for binding to their respective flagellins. These data implicate terminal sialic acid as part of the LAH strain-specific epitopes. However, using mutants in genes affecting LAH serorecognition of flagellin it was demonstrated that sialic acid alone is not the LAH epitope. Rather, the epitope(s) is complex, probably involving multiple glycosyl and/or amino acid residues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8825782     DOI: 10.1046/j.1365-2958.1996.370890.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  40 in total

1.  Localized reversible frameshift mutation in the flhA gene confers phase variability to flagellin gene expression in Campylobacter coli.

Authors:  S F Park; D Purdy; S Leach
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

Review 2.  Motility and chemotaxis in Campylobacter and Helicobacter .

Authors:  Paphavee Lertsethtakarn; Karen M Ottemann; David R Hendrixson
Journal:  Annu Rev Microbiol       Date:  2011       Impact factor: 15.500

3.  Structural and genetic characterization of glycosylation of type a flagellin in Pseudomonas aeruginosa.

Authors:  M Schirm; S K Arora; A Verma; E Vinogradov; P Thibault; R Ramphal; S M Logan
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

Review 4.  Posttranslational protein modification in Archaea.

Authors:  Jerry Eichler; Michael W W Adams
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

5.  A sigma28-regulated nonflagella gene contributes to virulence of Campylobacter jejuni 81-176.

Authors:  Scarlett Goon; Cheryl P Ewing; Maria Lorenzo; Dawn Pattarini; Gary Majam; Patricia Guerry
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Effects of glycosylation on swimming ability and flagellar polymorphic transformation in Pseudomonas syringae pv. tabaci 6605.

Authors:  Fumiko Taguchi; Satoshi Shibata; Tomoko Suzuki; Yujiro Ogawa; Shin-Ichi Aizawa; Kasumi Takeuchi; Yuki Ichinose
Journal:  J Bacteriol       Date:  2007-11-16       Impact factor: 3.490

Review 7.  Novel approaches for Campylobacter control in poultry.

Authors:  Jun Lin
Journal:  Foodborne Pathog Dis       Date:  2009-09       Impact factor: 3.171

8.  Cloning and comparison of fliC genes and identification of glycosylation in the flagellin of Pseudomonas aeruginosa a-type strains.

Authors:  C D Brimer; T C Montie
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

9.  A new class of Caulobacter crescentus flagellar genes.

Authors:  G Leclerc; S P Wang; B Ely
Journal:  J Bacteriol       Date:  1998-10       Impact factor: 3.490

10.  An extracellular glycoprotein is implicated in cell-cell contacts in the toxic cyanobacterium Microcystis aeruginosa PCC 7806.

Authors:  Yvonne Zilliges; Jan-Christoph Kehr; Stefan Mikkat; Christiane Bouchier; Nicole Tandeau de Marsac; Thomas Börner; Elke Dittmann
Journal:  J Bacteriol       Date:  2008-02-15       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.